Cargando…

Performance of BioFire Blood Culture Identification 2 Panel (BCID2) for the detection of bloodstream pathogens and their associated resistance markers: a systematic review and meta-analysis of diagnostic test accuracy studies

BACKGROUND: Early identification of bloodstream pathogens and their associated antimicrobial resistance may shorten time to optimal therapy in patients with sepsis. The BioFire Blood Culture Identification 2 Panel (BCID2) is a novel multiplex PCR detecting 43 targets directly from positive blood cul...

Descripción completa

Detalles Bibliográficos
Autores principales: Peri, Anna Maria, Ling, Weiping, Furuya-Kanamori, Luis, Harris, Patrick N. A., Paterson, David L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9585790/
https://www.ncbi.nlm.nih.gov/pubmed/36266641
http://dx.doi.org/10.1186/s12879-022-07772-x
_version_ 1784813568143654912
author Peri, Anna Maria
Ling, Weiping
Furuya-Kanamori, Luis
Harris, Patrick N. A.
Paterson, David L.
author_facet Peri, Anna Maria
Ling, Weiping
Furuya-Kanamori, Luis
Harris, Patrick N. A.
Paterson, David L.
author_sort Peri, Anna Maria
collection PubMed
description BACKGROUND: Early identification of bloodstream pathogens and their associated antimicrobial resistance may shorten time to optimal therapy in patients with sepsis. The BioFire Blood Culture Identification 2 Panel (BCID2) is a novel multiplex PCR detecting 43 targets directly from positive blood cultures, reducing turnaround times. METHODS: We have performed a systematic review and meta-analysis of diagnostic test accuracy studies to assess the BCID2 performance for pathogen identification and resistance markers detection compared to gold standard culture-based methods (including phenotypic and/or genotypic characterization). RESULTS: Nine studies were identified reporting data to build 2 × 2 tables for each BCID2 target, including 2005 blood cultures. The pooled specificity of the assay was excellent (> 97%) across most subgroups of targets investigated, with a slightly broader confidence interval for S. epidermidis (98.1%, 95% CI 93.1 to 99.5). Pooled sensitivity was also high for the major determinants of bloodstream infection, including Enterobacterales (98.2%, 95% CI 96.3 to 99.1), S. aureus (96.0%, 95% CI 90.4 to 98.4), Streptococcus spp. (96.7%, 95% CI 92.8 to 98.5), P. aeruginosa (92.7%, 95% CI 83.1 to 97.0), E. faecalis (92.3%, 95% CI 83.5 to 96.6), as well as bla(CTX-M) (94.9, 95% CI 85.7 to 98.3), carbapenemases (94.9%, 95% CI 83.4 to 98.6) and mecA/C & MREJ (93.9%, 95% CI 83.0 to 98.0). Sensitivity for less common targets was slightly lower, possibly due to their under-representation in the included studies. CONCLUSIONS: BCID2 showed good performance for detecting major determinants of bloodstream infection and could support early antimicrobial treatment, especially for ESBL or carbapenemase-producing Gram-negative bacilli and methicillin-resistant S. aureus. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12879-022-07772-x.
format Online
Article
Text
id pubmed-9585790
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-95857902022-10-22 Performance of BioFire Blood Culture Identification 2 Panel (BCID2) for the detection of bloodstream pathogens and their associated resistance markers: a systematic review and meta-analysis of diagnostic test accuracy studies Peri, Anna Maria Ling, Weiping Furuya-Kanamori, Luis Harris, Patrick N. A. Paterson, David L. BMC Infect Dis Research Article BACKGROUND: Early identification of bloodstream pathogens and their associated antimicrobial resistance may shorten time to optimal therapy in patients with sepsis. The BioFire Blood Culture Identification 2 Panel (BCID2) is a novel multiplex PCR detecting 43 targets directly from positive blood cultures, reducing turnaround times. METHODS: We have performed a systematic review and meta-analysis of diagnostic test accuracy studies to assess the BCID2 performance for pathogen identification and resistance markers detection compared to gold standard culture-based methods (including phenotypic and/or genotypic characterization). RESULTS: Nine studies were identified reporting data to build 2 × 2 tables for each BCID2 target, including 2005 blood cultures. The pooled specificity of the assay was excellent (> 97%) across most subgroups of targets investigated, with a slightly broader confidence interval for S. epidermidis (98.1%, 95% CI 93.1 to 99.5). Pooled sensitivity was also high for the major determinants of bloodstream infection, including Enterobacterales (98.2%, 95% CI 96.3 to 99.1), S. aureus (96.0%, 95% CI 90.4 to 98.4), Streptococcus spp. (96.7%, 95% CI 92.8 to 98.5), P. aeruginosa (92.7%, 95% CI 83.1 to 97.0), E. faecalis (92.3%, 95% CI 83.5 to 96.6), as well as bla(CTX-M) (94.9, 95% CI 85.7 to 98.3), carbapenemases (94.9%, 95% CI 83.4 to 98.6) and mecA/C & MREJ (93.9%, 95% CI 83.0 to 98.0). Sensitivity for less common targets was slightly lower, possibly due to their under-representation in the included studies. CONCLUSIONS: BCID2 showed good performance for detecting major determinants of bloodstream infection and could support early antimicrobial treatment, especially for ESBL or carbapenemase-producing Gram-negative bacilli and methicillin-resistant S. aureus. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12879-022-07772-x. BioMed Central 2022-10-20 /pmc/articles/PMC9585790/ /pubmed/36266641 http://dx.doi.org/10.1186/s12879-022-07772-x Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research Article
Peri, Anna Maria
Ling, Weiping
Furuya-Kanamori, Luis
Harris, Patrick N. A.
Paterson, David L.
Performance of BioFire Blood Culture Identification 2 Panel (BCID2) for the detection of bloodstream pathogens and their associated resistance markers: a systematic review and meta-analysis of diagnostic test accuracy studies
title Performance of BioFire Blood Culture Identification 2 Panel (BCID2) for the detection of bloodstream pathogens and their associated resistance markers: a systematic review and meta-analysis of diagnostic test accuracy studies
title_full Performance of BioFire Blood Culture Identification 2 Panel (BCID2) for the detection of bloodstream pathogens and their associated resistance markers: a systematic review and meta-analysis of diagnostic test accuracy studies
title_fullStr Performance of BioFire Blood Culture Identification 2 Panel (BCID2) for the detection of bloodstream pathogens and their associated resistance markers: a systematic review and meta-analysis of diagnostic test accuracy studies
title_full_unstemmed Performance of BioFire Blood Culture Identification 2 Panel (BCID2) for the detection of bloodstream pathogens and their associated resistance markers: a systematic review and meta-analysis of diagnostic test accuracy studies
title_short Performance of BioFire Blood Culture Identification 2 Panel (BCID2) for the detection of bloodstream pathogens and their associated resistance markers: a systematic review and meta-analysis of diagnostic test accuracy studies
title_sort performance of biofire blood culture identification 2 panel (bcid2) for the detection of bloodstream pathogens and their associated resistance markers: a systematic review and meta-analysis of diagnostic test accuracy studies
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9585790/
https://www.ncbi.nlm.nih.gov/pubmed/36266641
http://dx.doi.org/10.1186/s12879-022-07772-x
work_keys_str_mv AT periannamaria performanceofbiofirebloodcultureidentification2panelbcid2forthedetectionofbloodstreampathogensandtheirassociatedresistancemarkersasystematicreviewandmetaanalysisofdiagnostictestaccuracystudies
AT lingweiping performanceofbiofirebloodcultureidentification2panelbcid2forthedetectionofbloodstreampathogensandtheirassociatedresistancemarkersasystematicreviewandmetaanalysisofdiagnostictestaccuracystudies
AT furuyakanamoriluis performanceofbiofirebloodcultureidentification2panelbcid2forthedetectionofbloodstreampathogensandtheirassociatedresistancemarkersasystematicreviewandmetaanalysisofdiagnostictestaccuracystudies
AT harrispatrickna performanceofbiofirebloodcultureidentification2panelbcid2forthedetectionofbloodstreampathogensandtheirassociatedresistancemarkersasystematicreviewandmetaanalysisofdiagnostictestaccuracystudies
AT patersondavidl performanceofbiofirebloodcultureidentification2panelbcid2forthedetectionofbloodstreampathogensandtheirassociatedresistancemarkersasystematicreviewandmetaanalysisofdiagnostictestaccuracystudies